165 related articles for article (PubMed ID: 33096476)
21. HNRNPU-AS1 Regulates Cell Proliferation and Apoptosis via the MicroRNA 205-5p/AXIN2 Axis and Wnt/β-Catenin Signaling Pathway in Cervical Cancer.
Niu Z; Wang F; Lv S; Lv Y; Liu M; Fu L; Yao Y; Wang L; Lin W; Yuan F
Mol Cell Biol; 2021 Sep; 41(10):e0011521. PubMed ID: 34309414
[TBL] [Abstract][Full Text] [Related]
22. The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer.
Jiang W; He T; Liu S; Zheng Y; Xiang L; Pei X; Wang Z; Yang H
J Hematol Oncol; 2018 Dec; 11(1):139. PubMed ID: 30547809
[TBL] [Abstract][Full Text] [Related]
23. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation.
Zhou S; Bai ZL; Xia D; Zhao ZJ; Zhao R; Wang YY; Zhe H
Mol Carcinog; 2018 May; 57(5):590-597. PubMed ID: 29315835
[TBL] [Abstract][Full Text] [Related]
24. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.
Halle MK; Ojesina AI; Engerud H; Woie K; Tangen IL; Holst F; Høivik E; Kusonmano K; Haldorsen IS; Vintermyr OK; Trovik J; Bertelsen BI; Salvesen HB; Krakstad C
Am J Obstet Gynecol; 2017 Oct; 217(4):432.e1-432.e17. PubMed ID: 28599900
[TBL] [Abstract][Full Text] [Related]
26. Myo-inositol reduces β-catenin activation in colitis.
Bradford EM; Thompson CA; Goretsky T; Yang GY; Rodriguez LM; Li L; Barrett TA
World J Gastroenterol; 2017 Jul; 23(28):5115-5126. PubMed ID: 28811707
[TBL] [Abstract][Full Text] [Related]
27. Aberrant Methylation of the SOX21-AS1 Promoter Region Promotes Gene Expression and Its Clinical Value in Cervical Cancer.
Du P; Zhi Y; Wang R; Li Y; Li H; Zhang X; Cheng G; Li X
Reprod Sci; 2021 Feb; 28(2):532-540. PubMed ID: 33095426
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency ablation for dysplasia in Barrett's esophagus restores β-catenin activation within esophageal progenitor cells.
Krishnan K; Komanduri S; Cluley J; Dirisina R; Sinh P; Ko JZ; Li L; Katzman RB; Barrett TA
Dig Dis Sci; 2012 Feb; 57(2):294-302. PubMed ID: 21948356
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
30. Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/β-catenin signaling.
Li H; Zhang W; Yan M; Qiu J; Chen J; Sun X; Chen X; Song L; Zhang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):33. PubMed ID: 30678687
[TBL] [Abstract][Full Text] [Related]
31. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
[TBL] [Abstract][Full Text] [Related]
32. Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression.
Cui N; Yang WT; Zheng PS
Oncotarget; 2016 May; 7(18):26152-67. PubMed ID: 27036045
[TBL] [Abstract][Full Text] [Related]
33. Activation of Wnt-β-catenin pathway in basal-parabasal layers of normal cervical epithelium comparable during development of uterine cervical carcinoma.
Chakraborty C; Samadder S; Roychowdhury A; Roy A; Das P; Mandal RK; Roychoudhury S; Panda CK
Mol Cell Biochem; 2018 Jun; 443(1-2):121-130. PubMed ID: 29079964
[TBL] [Abstract][Full Text] [Related]
34. Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma.
Park AK; Kim P; Ballester LY; Esquenazi Y; Zhao Z
Neuro Oncol; 2019 Jan; 21(1):59-70. PubMed ID: 30053126
[TBL] [Abstract][Full Text] [Related]
35. Promoter methylation analysis of WNT/β-catenin signaling pathway regulators to detect adenocarcinoma or its precursor lesion of the cervix.
van der Meide WF; Snellenberg S; Meijer CJ; Baalbergen A; Helmerhorst TJ; van der Sluis WB; Snijders PJ; Steenbergen RD
Gynecol Oncol; 2011 Oct; 123(1):116-22. PubMed ID: 21726894
[TBL] [Abstract][Full Text] [Related]
36. Methylomics analysis identifies epigenetically silenced genes and implies an activation of β-catenin signaling in cervical cancer.
Chen YC; Huang RL; Huang YK; Liao YP; Su PH; Wang HC; Chang CC; Lin YW; Yu MH; Chu TY; Lai HC
Int J Cancer; 2014 Jul; 135(1):117-27. PubMed ID: 24310984
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/β-catenin pathway.
Liu CN; Zhang HY; Liu CL; Wang CC
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5611-5620. PubMed ID: 31298313
[TBL] [Abstract][Full Text] [Related]
38. Wnt signaling in triple negative breast cancer is associated with metastasis.
Dey N; Barwick BG; Moreno CS; Ordanic-Kodani M; Chen Z; Oprea-Ilies G; Tang W; Catzavelos C; Kerstann KF; Sledge GW; Abramovitz M; Bouzyk M; De P; Leyland-Jones BR
BMC Cancer; 2013 Nov; 13():537. PubMed ID: 24209998
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway.
Wang CH; Li YH; Tian HL; Bao XX; Wang ZM
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244
[TBL] [Abstract][Full Text] [Related]
40. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
